Policy & Regulations

This channel includes news coverage of healthcare policy and regulations set by Congress, the states, Centers for Disease Control and Prevention (CDC), the Department of Health and Human Services (HHS), U.S. Food and Drug Administration (FDA), and medical associations and societies. 

Hospital financial trouble

AHA urges hospital stakeholders to wake up and smell the financial trouble that’s been brewing

The American Hospital Association is sounding the alarm over evidently widespread acceptance of 0% operating margins—or even negative margins—as a sort of “new normal” for U.S. hospitals and health systems.  

TikTok doc loses medical license after livestreaming procedures on social media

At least 11 patients have come forward regarding severe complications stemming from treatments and procedures completed by "Dr. Roxy."

Thumbnail

Healthcare industry to be impacted by OSHA's new injury/illness reporting requirements

The new rule on reporting work-related injuries and illnesses is set to take effect on January 1, 2024.

Thumbnail

HHS launches federal investigation into Cedars-Sinai's treatment of Black mothers

The civil rights probe follows a wrongful death lawsuit filed by Charles Johnson IV after the untimely death of his wife, who had undergone a planned cesarean section in 2016.

the words "FDA recall" on a board

Medtronic recalls nearly 350,000 implantable heart devices after 22 injuries

The FDA has categorized this as a Class I recall, meaning the use of these devices could cause serious injuries or death.”

fda approves first daily oral birth control

FDA approves first nonprescription daily birth control in US

Opill (norgestrel) is a progestin-only daily oral contraceptive that can be purchased without prescription at drug stores, convenience stores, grocery stores and online once it becomes available to consumers.

artificial intelligence healthcare providers legal

3 AI to-do’s for legally aware healthcare providers

Healthcare providers might be the most underrated of all AI stakeholders. Never mind that close to half of 200 CEOs surveyed believe healthcare is the field in which AI is likely to make the most transformative contribution.

Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter

FDA says treating PAD with paclitaxel-coated devices does not increase mortality risk

After warning healthcare providers about a heightened risk of mortality back in 2019, the FDA has now updated its stance on the use of these devices. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.